|
|
Article: Actonel significantly reduced fractures in high-risk women.
- Article from:
- Women's Health Weekly
- Article date:
- March 13, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 MAR 13 - (NewsRx.com & NewsRx.net) -- Newly published data show that treatment with 5 mg Actonel (risedronate sodium tablets) daily reduced the risk of spinal fracture in postmenopausal osteoporotic patients at higher risk of fracture because of age or low bone mineral density (BMD) at the hip.
In these patients, fracture risk was reduced by 62% and 60%, respectively, at 1 year with Actonel compared with placebo. The analysis of combined data from two studies was published in the February issue of the Journal of Clinical Endocrinology and Metabolism, and also shows that the fracture reduction benefits of Actonel in patients at higher risk of fracture were ...